N-Fmoc-2-methylbenzyl-glycine is an aromatic glycine derivative where ortho-methyl substitution introduces steric asymmetry. The residue influences side-chain orientation and hydrophobic clustering in designed peptides. Researchers employ it for linker design and conformational tuning. Its Fmoc protection supports multistep synthetic schemes.
CAT No: R2149
CAS No:2137983-02-7
Synonyms/Alias:N-Fmoc-2-methylbenzyl-glycine;2137983-02-7;{[(9H-fluoren-9-ylmethoxy)carbonyl][(2-methylphenyl)methyl]amino}acetic acid;EN300-81242;F80953;2-[9H-fluoren-9-ylmethoxycarbonyl-[(2-methylphenyl)methyl]amino]acetic acid;N-(((9H-FLUOREN-9-YL)METHOXY)CARBONYL)-N-(2-METHYLBENZYL)GLYCINE;2-({[(9H-fluoren-9-yl)methoxy]carbonyl}[(2-methylphenyl)methyl]amino)acetic acid;
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.